Search Within

Tanya M Trippett

Formats
  1. Journal Article (63)
  2. Meeting Abstract (63)
Groups
  1. Center for Hematologic Malignancies (126)
  2. Hematologic Malignancies Service (126)
  3. Pediatric Leukemia (126)
  4. Pediatrics, Department of (126)
  5. Department of Medicine (23)
  6. Survivorship Research (19)

More Groups

People
  1. Joseph Bertino (16)
  2. Peter Steinherz (16)
  3. Craig Moskowitz (12)
  4. Ira Dunkel (11)
  5. Neerav Shukla (11)
  6. Erdem Goker (9)

More People

Years
  1. 2025 (2)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (5)
  5. 2020 (6)
  6. 2019 (4)

More Years

Publications
  1. Pediatric Blood and Cancer (26)
  2. Blood (23)
  3. Journal of Clinical Oncology (15)
  4. Clinical Cancer Research (4)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (4)
  6. Cancer Research (3)

More Publications

Publishers
  1. Wiley Periodicals, Inc (26)
  2. American Society of Hematology (24)
  3. American Society of Clinical Oncology (15)
  4. American Association for Cancer Research (11)
  5. Nature Publishing Group (6)
  6. Elsevier Inc. (5)

More Publishers

Results (126)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Re-exposure to blinatumomab after CD19-positive relapse: Experience from three trials in patients (pts) with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R ALL)
    Meeting Abstract

    Topp, M. S.; Stelljes, M.; Zugmaier, G.; Barnette, P.; Heffner, L. T.; Trippett, T. M.; Bargou, R. C.; Holland, C.; Benjamin, J.; Litzow, M. R.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: A Children's Oncology Group study
    Journal Article

    Horton, T. M.; Drachtman, R. A.; Chen, L.; Cole, P. D.; McCarten, K.; Voss, S.; Guillerman, R. P.; Buxton, A.; Howard, S. C.; Hogan, S. M.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation (alloHSCT) following blinatumomab-induced remission in pediatric patients with relapsed/refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL): Preliminary results from a phase I/II stud
    Meeting Abstract

    Handgretinger, R.; Gore, L.; Zugmaier, G.; Locatelli, F.; Zwaan, C. M.; Bhojwani, D.; Bader, P.; O'Brien, M. M.; Trippett, T. M.; Brethon, B.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma
    Journal Article

    Illidge, T.; Bouabdallah, R.; Chen, R.; Gopal, A. K.; Moskowitz, C. H.; Ramchandren, R.; Shustov, A. R.; Tilly, H.; Trippett, T. M.; Gibb, A.; more...
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: A Children's Oncology Group report
    Journal Article

    Trippett, T. M.; Schwartz, C. L.; Guillerman, R. P.; Gamis, A. S.; Gardner, S.; Hogan, S.; London, W. B.; Chen, L.; de Alarcon, P.
    Pediatric Blood and Cancer (2015)

    Fulltext@MSK | Save
  • Phase 1/2 study in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL) receiving blinatumomab treatment
    Meeting Abstract

    Von Stackelberg, A.; Locatelli, F.; Zugmaier, G.; Handgretinger, R.; Trippett, T. M.; Rizzari, C.; Zwaan, C. M.; Bhojwani, D.; DuBois, S. G.; Bader, P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Initial results from a phase 2 study of blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Meeting Abstract

    Gore, L.; Locatelli, F.; Zugmaier, G.; Zwaan, C. M.; Bhojwani, D.; Handgretinger, R.; Bader, P.; O'Brien, M. M.; Trippett, T. M.; Brethon, B.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Interim analysis of a phase 1 study of the antibody-drug conjugate SGN-CD19A in relapsed or refractory B-lineage acute leukemia and highly aggressive lymphoma
    Meeting Abstract

    Fathi, A. T.; Chen, R.; Trippett, T. M.; O'Brien, M. M.; DeAngelo, D. J.; Shah, B. D.; Cooper, T. M.; Foran, J. M.; Hale, G. A.; Pressey, J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Druggability of p16 deleted pediatric leukemia: The novel cell line POETIC3 identifies potential agents and drug combinations for mechanism based targeted therapeutics
    Meeting Abstract

    Reimer, J.; Kovulchuk, A.; Ruan, Y.; Shah, R.; Jayanthan, A.; Perinpanayagam, M.; Truong, T.; Auer-Grzesiak, I.; Luider, J.; Kovulchuk, O.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save